Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy

Summary

This is a prospective randomized controlled, open-labeled study to identify the efficacy of probucol in combination with valsartan in patients with Diabetes nephropathy. The reduction of urinary albumin or proteinuria will be the primary outcome studied. The expected study duration will be 48 weeks.

Timeline

Start

2008-05

Primary completion

2017-05

Completion

2017-05

Drugs

Indications